Liv.52 Tablets (Regular Strength)
The original Liv.52 tablets.
Liv.52 Tablets (Double Strength)
As the original Liv.52 tablets, but double strength.
Liv.52 Syrup
Easy to take Liv.52 syrup, popular with the elderly.
Liv.52 HB
For the treatment of Hepatitis B.
Liv.52 Vet
Liv.52 Drops and syrup for Cats, Dogs, Kittens and Puppies.
Cytozen
Specially formulated for alcoholic liver diseases.
Livomyn
The only hepatoprotector with the L factor.
Party Smart
Prevent hangovers, protect the liver whist drinking alcohol.
Purim
Liver, Kidney and Blood detox.
Triphala
PURE HERB - Cleansing of Organs, Colon, Digestion, Blood Purifier and Rejuvenates.
Home Liver Test Kit
Test your liver condition in the privacy of your own home.
Home Family Health Screening Test Kit
Test your Liver, Kidney, Heart and Urinary Tract condition in the privacy of your own home.
** Discount Packages **
Discounted Product Combinations!
Liv 52 Ingredients
Liv 52 Research
Liv 52 Benefits
Liv 52 Liver Facts
Liv 52 Vs. Milk Thistle
Liv 52 for Anabolic Steroids
The safety of Liv.52 has been demonstrated by acute and chronic toxicity studies on animals and a phase 1 safety study in human volunteers. During the past 38 years, Liv.52 has been used by millions of patients in India and Europe and no adverse effects have been reported. The uniformity of the product is ensured by using authentic herbal material and by rigidly following the formulation processes according to the principles of Ayurveda. To read more about this study, visit A novel mechanism of action prevents ethanol-induced injury � Liv.52 profile of an herbal remedy - Chauhan, B.L. and Kulkarni, R.D., Drug News & Perspectives (1993): (6), 9, 662.
These cases were administered Liv.52 alone, in dose of 20 drops 3 times a day, for a year. No other medication was given during the period. At the end of one year on Liv.52, 56.5% cases were adequately controlled and showed clinical and biochemical improvement. Serum Alpha-I-AT levels were significantly higher (p<0.01) in both non-deficient and deficient cases of cirrhosis following one year�s therapy with Liv.52. To read more about this study, visit Role of Liv.52 in Indian childhood cirrhosis, with special reference to its effect on Alpha-I-Antitrypsin levels - Nawal Kishore Agrawal, Prasad, R., Manju Sharma and Sharma, B.B., Asian Medical Journal (1982): 9, 647.
- The efficacy of Liv-52 on liver cirrhotic patients: A randomized,
double-blind, placebo-controlled first approach (pdf)
H. Fallah Huseinia*, S.M. Alavianb, R. Heshmatc, M.R. Heydarid, K. Abolmaalie a Department of Pharmacology, Institute of Medicinal Plants, No. 97, Bozorgmehr St., Ghods St., Enghelab Ave., Tehran, Iran. b Baqiatallah University of Medical Sciences, Tehran Hepatitis Center, Tehran, Iran. c Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran. d Endocrinology & Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran. e Baqiatallah University of Medical Sciences, Tehran, Iran Phytomedicine 12(2005) 619-624. - A
novel mechanism of action prevents ethanol-induced injury – Liv.52 profile of an herbal remedy (pdf)
Chauhan, B.L. and Kulkarni, R.D., R&D Centre, The Himalaya Drug Co., Bangalore, Karnataka, Drug News & Perspectives (1993): (6), 9, 662. - Liv.52
in the management of various hepatic disorders – A study
of 53 cases (pdf)
Bharadia, G.R., Kukade, A.L., Kulkarni, A.S. and Rathod, I.M., Vivekanand Hospital, Latur, Maharastra, Probe (1986): (XXV), 3, 277. - Role
of Liv.52 in Indian childhood cirrhosis, with special reference
to its effect on alpha-I-antitrypsin levels (pdf)
Nawal Kishore Agrawal, Prasad, R., Manju Sharma and Sharma, B.B., S.N. Medical College and Hospital, Agra, Uttar Pradesh, Asian Medical Journal (1982): 9, 647. - Role
of Liv.52 in management of Indian childhood cirrhosis (pdf)
Shakuntala Saxena (Mrs.), Ashok Kumar Garg and Ashok Jain, Department of Paediatrics, S.M.S. Medical College and Hospital, Jaipur, Rajasthan, Current Medical Practice. (1980): (24), 7, 269. - Role
of Liv.52 in hepatic and cirrhosis of the liver (pdf)
Mallik K.K. and Pal, M.B., Department of Medicine, Institute of Postgraduate Medical Education and Research, Calcutta, West Bengal, Current Medical Practice (1979): 23, 5. - Liv.52
in the treatment of cirrhosis of liver – Certain observations (pdf)
Singh, K.K., Department of Medicine, Singh, Y.K., Dubey, K.M., Department of Biochemistry, Sharma, V., Department of Medicine, and Mishra, B.N., Darbhanga Medical College, Laheriasarai, Bihar, The Antiseptic (1979): (76), 7, 393. - A
study of therapeutic actions of Liv.52 on various stages, severity,
and activity of portal cirrhosis and infective hepatitis (pdf)
Sinha, P.K., B.R.D. Medical College, Gorakhpur, Uttar Pradesh, Ashok Kumar and Patney, N.L., Post-graduate Department of Medicine, S.N. Medical College, Uttar Pradesh, Probe (1979): (XVIII), 3, 157. - Study
of Liv.52 therapy in cases of Indian childhood cirrhosis and other
liver disorders (pdf)
Mehar Singh and Agrawal, V.K., S.N. Children’s Hospital, M.L.N. Medical College, Allahabad, Uttar Pradesh, Probe (1978): (XVII), 2, 169. - Management
of steatorrhoea of cirrhosis of the liver by an indigenous drug
– Liv.52 (pdf)
Patney, N.L., Jasuja, R.K. and Ashok Kumar, Postgraduate Department of Medicine, S.N. Medical College, Agra, Uttar Pradesh, Probe (1976): (XV), 3, 164. - Liv.52
– A clinico-biochemical trial in hepatic cirrhosis (pdf)
Mehrotra, M.P. and Tandan, S., S.N. Medical College, Agra, Uttar Pradesh, Current Medical Practice (1973): (17), 4, 185. - Hepatic
cirrhosis in the tropics (pdf)
Mukerjee, A.B., Calcutta National Medical College and Hospital, Calcutta, West Bengal, Dasgupta, M., Resident University of Tennessee College of Medicine, USA, and Sarkar, S.K., N R Sarkar Medical College, Calcutta, West Bengal, Probe (1973): (XII), 2, 91. - Liv.52
– A new therapeutic agent in the management of steatorrhoea
of cirrhosis of the liver (pdf)
Patney, N.L., Jasuja, R.K. and Ashok Kumar, Postgraduate Department of Medicine, S.N. Medical College, Agra, Uttar Pradesh, Journal of Research in Indian Medicine (1973): 3, 28. - Long-term
studies on the therapy of hepatic damage and cirrhosis of liver (pdf)
Lala Surajnandan Prasad, Patna Medical College and Prince of Wales Hospital, Patna, Bihar Sinha, K.N., Prince of Wales Hospital, Patna, Bihar, Devendra Tripathy and Prasad, K., Research Scholar, Patna, Bihar, Current Medical Practice (1971): (15), 12, 1071. - Cirrhosis
of liver – Results of treatment with an indigenous drug:
Liv.52 (pdf)
Mukerjee, A.B. and Dasgupta, M., Department of Medicine, Ramakrishna Mission Seva Pratishthan, Calcutta, West Bengal, Journal of Indian Medical Profession (1971): 17, 7853. - B.S.P.
test in the evaluation of therapy in hepatic cirrhosis by an indigenous
drug – Liv.52 (pdf)
Dasgupta, M., Ramakrishna Mission Seva Pratishthan, Calcutta, West Bengal,and Mukerjee, A.B., Calcutta National Medical College and Hospitals, Calcutta, West Bengal, The Indian Practitioner (1970): 12, 739. - Cirrhosis
of liver (pdf)
Shantilal C. Sheth and Tibrewala, N.S., Bharat Medical Journal (1970): (2), 2, 130. - Liv.52
– Infantile cirrhosis (pdf)
Paulose, P.M., The Indian Practitioner (1963): 6, 516. - Clinical
and histopathological evaluation of Liv.52 in cirrhosis in liver (pdf)
Vyas, K.J., General Hospital, Junagadh, Gujarat, Probe (1963): 2, 66. - Treatment
of hepatopathy in children with a combination of capparis spinosa
and other Indian indigenous drugs (pdf)
Vyas, K.J., Children Ward, General Hospital, Junagadh, Gujarat, Medical Digest (1961): (29), 3, 105. - Therapy
of cirrhosis of liver and liver damage with indigenous drugs –
Experimental and clinical studies (pdf)
Shantilal C. Sheth, Basil J. Northover, Tibrewala, N.S., Warerkar, U.R. and Karande, V.S. B.Y.L. Nair Hosptial and Topiwala National Medical College and the Christian Medical College and Hospital, Vellore, Tamil Nadu, Indian Journal of Paediatrics (1960): 27, 204. - Liv.52
therapy in cirrhosis of liver in children (pdf)
Vyas, K.J., Indian Journal of Child Health (1960): 5, 244. - Treatment
of infantile cirrhosis with an indigenous preparation (pdf)
Vyas, K.J., Children Hospital, Sir T. Hospital, Bhavnagar, Gujarat, The Indian Practitioner (1958): (XI), 1, 107. - Some
clinical observations on the use of Liv.52 (An indigenous drug)
in cases of cirrhosis of liver in children (pdf)
Mathur, P.S., Hamidia Hospital, Bhopal, Madhya Pradesh, Current Medical Practice (1957): 5, 107.